Membership
Coulter Partners appoints Dr. Hannah Musisi as Executive Director
Coulter Partners announces the appointment of Dr. Hannah Musisi as Executive Director, based in London. Hannah will support our work in the Digital Health sector, working closely with Ian Coyne, Executive Director.
Bianca Coulter, CEO of Coulter Partners said: “As part of our broad offering across science, technology and innovation, we have been working more and more in the Digital Health sector. With her consulting, sales and growth expertise, particularly in Digital Health and media, we are so excited to work with Hannah to further our understanding of this sector and its needs.”
Commenting on her appointment, Hannah Musisi, Executive Director, said: “There are still huge problems with accessibility to healthcare and I am fascinated by tackling these at the cutting edge and cross-section of innovation in health and technology. I am hugely impressed by the work Coulter Partners is already doing in this fast-growing sector and I am looking forward to contributing my knowledge and ideas to drive further growth.”
Hannah focuses on organizational and leadership advisory services, particularly in Digital Health, drawing on deep expertise in commercial strategy, business development and growing new businesses. She specializes in the impact of digital transformation in healthcare.
Hannah brings over 20 years of experience across consulting, sales, and growth in diverse sectors including energy, media, and Digital Health. She joins Coulter Partners from her own consultancy where she provided strategic, commercial, and operational advice to Digital Health start-ups and technology companies, including Digital Therapeutics and Telemedicine companies Babylon Health and Big Health. She brings prior experience in the digital media industry, most recently with Bloomberg as Head of TV Distribution in EMEA, as well as in strategy consulting with KPMG. Hannah holds an MBA from Collège des Ingénieurs, Paris, France, a PhD in Molecular Genetics from the University of Cambridge, UK, and a BSc. in Biochemistry from Imperial College, London, UK. She is a native English speaker with business French.
